FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:337-342 February 3, 1994 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Ascites is the pathologic accumulation of fluid in the peritoneal cavity. The condition develops most frequently as part of the decompensation of previously asymptomatic chronic liver disease (Table 1). Ascites is the most common complication of such disease, occurring in 50 percent of patients within 10 years of a diagnosis of compensated cirrhosis; in comparison, variceal bleeding develops in only 25 percent². The development of fluid retention in a person with chronic liver disease is a poor prognostic sign; only 50 percent of such people survive two years³. The prognosis of patients with noncirrhotic ascites is . . . [Full Text of this Article]

Abdominal Paracentesis and Analysis of Ascitic Fluid

Treatment of Patients with Cirrhosis and Ascites

Diuretic-Resistant Ascites

Source Information

From the Department of Internal Medicine, University of Iowa College of Medicine, Iowa City.

Address reprint requests to Dr. Runyon at the Division of Gastroenterology/Hepatology, Department of Medicine, University of Louisville, Louisville, KY 40292.

References

Related Letters:

Care of Patients with Ascites
Kaufman J. L., Gerbes A.L., Scholmerich J., Montero E., Miguel J., Lopez-Alvarez J., Runyon B. A.
Extract | Full Text  
N Engl J Med 1994; 330:1827-1828, Jun 23, 1994. Correspondence

This article has been cited by other articles:

• Kashani, A., Landaverde, C., Medici, V., Rossaro, L. (2008). Fluid retention in cirrhosis: pathophysiology and management. QJM 101: 71-85 [Abstract] [Full Text]  
• Ayantunde, A., Parsons, S. (2007). Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 18: 945-949 [Abstract] [Full Text]  
• Ferral, H., Gamboa, P., Postoak, D. W., Albernaz, V. S., Young, C. R., Speeg, K. V., McMahan, C. A. (2004). Survival after Elective Transjugular Intrahepatic Portosystemic Shunt Creation: Prediction with Model for End-Stage Liver Disease Score. Radiology 231: 231-236 [Abstract] [Full Text]  
• Gulyas, M, Kaposi, A D, Elek, G, Szollar, L G, Hjerpe, A (2001). Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology. J. Clin. Pathol. 54: 831-835 [Abstract] [Full Text]  
• Hauer, K. E., Winawer, N. (2000). Update in Hospital Medicine. ANN INTERN MED 133: 707-713 [Full Text]  
• Rossle, M., Ochs, A., Gulberg, V., Siegerstetter, V., Holl, J., Deibert, P., Olschewski, M., Reiser, M., Gerbes, A. L. (2000). A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. NEJM 342: 1701-1707 [Abstract] [Full Text]  
• McNamara, P. (2000). Paracentesis - an effective method of symptom control in the palliative care setting?. Palliat Med 14: 62-64  
• Tangkijvanich, P., Tresukosol, D., Sampatanukul, P., Sakdikul, S., Voravud, N., Mahachai, V., Mutirangura, A. (1999). Telomerase Assay for Differentiating between Malignancy-related and Nonmalignant Ascites. Clin. Cancer Res. 5: 2470-2475 [Abstract] [Full Text]  
• Ochs, A., Rossle, M., Haag, K., Hauenstein, K.-H., Deibert, P., Siegerstetter, V., Huonker, M., Langer, M., Blum, H. E. (1995). The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Refractory Ascites. NEJM 332: 1192-1197 [Abstract] [Full Text]  
• Kaufman, J. L., Gerbes, A.L., Scholmerich, J., Montero, E., Miguel, J., Lopez-Alvarez, J., Runyon, B. A. (1994). Care of Patients with Ascites. NEJM 330: 1827-1828 [Full Text]